Scarica l'app Stockscreener
13.36
2.48%
-0.34
Dopo l'orario di chiusura:
13.82
0.46
+3.44%
Precedente Chiudi:
$13.70
Aprire:
$13.32
Volume 24 ore:
2.45M
Relative Volume:
0.90
Capitalizzazione di mercato:
$1.53B
Reddito:
$631.73M
Utile/perdita netta:
$-239.78M
Rapporto P/E:
-6.6139
EPS:
-2.02
Flusso di cassa netto:
$-33.45M
1 W Prestazione:
+0.15%
1M Prestazione:
+4.78%
6M Prestazione:
+58.48%
1 anno Prestazione:
-20.38%
Intervallo 1D:
$13.06
$13.84
Intervallo di 1 settimana:
$12.34
$13.85
Portata 52W:
$6.78
$18.21
10 X Genomics Inc Stock (TXG) Company Profile
Nome
10 X Genomics Inc
Settore
Industria
Telefono
(925) 401-7300
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Confronta TXG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
13.36 | 1.71B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
293.49 | 47.98B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
84.49 | 15.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.82 | 12.54B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.03 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.49 | 7.08B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-11 | Iniziato | Piper Sandler | Neutral |
| 2025-02-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-05-01 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-10 | Iniziato | Barclays | Overweight |
| 2023-03-31 | Iniziato | Stephens | Overweight |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-08-18 | Downgrade | Goldman | Neutral → Sell |
| 2022-07-25 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-15 | Iniziato | William Blair | Outperform |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-10 | Iniziato | Stifel | Buy |
| 2020-03-05 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-07 | Iniziato | BofA/Merrill | Buy |
| 2019-10-07 | Iniziato | Cowen | Outperform |
| 2019-10-07 | Iniziato | JP Morgan | Overweight |
| 2019-09-24 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
10 X Genomics Inc Borsa (TXG) Ultime notizie
Can a trend reversal in 10x Genomics Inc. lead to recoveryInsider Selling & AI Enhanced Trading Alerts - newser.com
10x Genomics Inc. stock outlook for YEARWeekly Market Summary & Real-Time Buy Signal Alerts - newser.com
Simon Quick Advisors LLC Makes New Investment in 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock a safe investment in uncertain marketsStop Loss & Daily Entry Point Trade Alerts - newser.com
Is 10x Genomics Inc. stock supported by strong fundamentalsJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
Is 10x Genomics Inc. (1KJ) stock undervalued historicallyWeekly Stock Report & Smart Swing Trading Techniques - newser.com
Brighton Jones LLC Takes $263,000 Position in 10x Genomics $TXG - MarketBeat
25,103 Shares in 10x Genomics $TXG Purchased by Focus Partners Advisor Solutions LLC - MarketBeat
10x Genomics (NASDAQ:TXG) Shares Up 10%What's Next? - MarketBeat
Sumitomo Mitsui Trust Group, Inc. Adjusts Holdings in 10x Genomi - GuruFocus
Advanced analytics toolkit walkthrough for 10x Genomics Inc.Portfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Ethic Inc. Invests $289,000 in 10x Genomics $TXG - MarketBeat
10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
10x Genomics (TXG) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research - Lelezard
ARK Investment Acquires New Shares in 10x Genomics (TXG) - GuruFocus
10x Genomics Launches New Chromium Flex for Single-Cell Research - Contract Pharma
10x Genomics (NASDAQ: TXG) launches Chromium Flex enabling 384-sample plate multiplexing - Stock Titan
Why 10x Genomics Inc. stock appeals to dividend seekers2025 Historical Comparison & AI Forecast Swing Trade Picks - fcp.pa.gov.br
Canaccord Genuity Keeps Their Buy Rating on 10x Genomics (TXG) - The Globe and Mail
IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases 184,757 Shares of 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock ready for a breakoutNew Guidance & Smart Allocation Stock Reports - newser.com
How geopolitical tensions affect 10x Genomics Inc. stockDividend Hike & Risk Controlled Daily Trade Plans - newser.com
What’s the recovery path for long term holders of 10x Genomics Inc.2025 Risk Factors & AI Based Trade Execution Alerts - newser.com
Is 10x Genomics Inc. stock dividend yield sustainable2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
How 10x Genomics Inc. stock trades before earningsCPI Data & Expert Curated Trade Setups - fcp.pa.gov.br
Sumitomo Mitsui Trust Group Inc. Acquires 654,597 Shares of 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Given Average Rating of "Hold" by Brokerages - MarketBeat
Ranking 10x Genomics Inc. among high performing stocks via toolsStop Loss & Fast Momentum Entry Tips - newser.com
Is 10x Genomics Inc. stock entering bullish territoryJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Is 10x Genomics Inc. (1KJ) stock nearing a technical breakoutWeekly Investment Recap & Smart Swing Trading Alerts - newser.com
Will 10x Genomics’ (TXG) AI Partnership Shift Its Long-Term Competitive Edge in Genomics? - Yahoo Finance
What momentum shifts mean for 10x Genomics Inc.July 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Globe and Mail
Lancaster Opens $7 Million Position in 10x Genomics (TXG) - The Motley Fool
Cookson Peirce & Co. Inc. Takes Position in 10x Genomics $TXG - MarketBeat
SPT Labtech and 10x Genomics Partner To Automate Single Cell Workflows - Technology Networks
10x Genomics and Prognosys Biosciences Allege Illumina Infringed Four Spatial Transcriptomics Patents - IPWatchdog.com
Why 10x Genomics Inc. (1KJ) stock trades below fair valueQuarterly Market Summary & Verified Chart Pattern Signals - newser.com
Will 10x Genomics Inc. stock gain from lower inflationEarnings Miss & Fast Gain Stock Trading Tips - newser.com
10x Genomics Hits Illumina With 2 Gene Tech Patent Suits - Law360
10x sues rival Illumina over gene-sequencing patents - Reuters
10x Genomics (TXG) Takes Legal Action Against Illumina Over Pate - GuruFocus
Illumina faces patent lawsuits from 10x Genomics over gene sequencing tech - Seeking Alpha
Illumina Hit with 10X Genomics Patent Suits Over Sequencing Tech - Bloomberg Law News
10x Genomics, Inc. (TXG) Stock Analysis: A 13.07% Potential Upside In Health Information Services - DirectorsTalk Interviews
10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance
10 X Genomics Inc Azioni (TXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.28%
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):